Use of polysulphated alginate in cellular matrices

Details Use of polysulphated alginate in cellular matrices Use of polysulphated alginate in cellular matrices

2011-08-02

2011-08-02

Ariani, Kade (Department: 1651)

Drug, bio-affecting and body treating compositions

Whole live micro-organism, cell, or virus containing

Animal or plant cell

Reexamination Certificate

active

07988962

ABSTRACT:
The present invention describes an in vitro/ex vivo method for the cultivation of connective tissue cells or progenitor cells (e.g. chondrogenic cells) in matrix comprising polysulphated alginate. These cultivated cells can be used in the preparation of a medicament for the treatment or prevention of osteochondral defects. The invention also describes a matrix comprising polysulphated alginate and mammalian connective tissue cells or progenitor cells thereof.

REFERENCES:
patent: 5705177 (1998-01-01), Roufa et al.
patent: 5705178 (1998-01-01), Roufa et al.
patent: 5994325 (1999-11-01), Roufa et al.
patent: 6020326 (2000-02-01), Roufa et al.
patent: 6083930 (2000-07-01), Roufa et al.
patent: 6127348 (2000-10-01), Roufa et al.
patent: 6417173 (2002-07-01), Roufa et al.
patent: 6756362 (2004-06-01), Roufa et al.
patent: 2003/0109493 (2003-06-01), Maximillen et al.
patent: 2003/0161884 (2003-08-01), Rosenberg et al.
patent: 1 027 893 (2000-08-01), None
patent: WO 98/11141 (1998-03-01), None
Kavalkovich et al. , In vitro Cell. Dev. Biol.—Animal, 2002, vol. 38, p. 457-466.
Ronghua et al., Carbohydrate Polymers, Apr. 2003, vol. 52, p. 19-24.
Kawada et al. , Arch Dermatol Res, 1999, vol. 291, p. 542-547.
Rihova B., Advanced Drug Delivery Reviews, 1996, vol. 21, p. 157-176.
Verbruggen et al., J Rheumatol., 1999, vol. 26 , p. 1663-1671.
Hauselmann et al., American Journal of physiology, 1996, vol. 271, p. C742-C752.
Almqvist et al., “Culture of Chondrocytes in Alginate Surrounded by Fibrin Gel: Characteristics of the Cells Over a Period of Eight Weeks,” Annals, of Rheumatic Diseases 60: 781-790 (2001).
Schwelger et al., Polysaccharide Sulfates II Sulfuric Acid Esters of Glycuronans Having Various Degrees of Substitution 21:275-281 (1972).
Verbruggen et al., “Influence of Polysulfated Polysaccharides on Aggrecans Synthesized by Differentiated Human Articular Chondrocytes,” The Journal of Rheumatology 26:1663-1671 (1999).
International Search Report (PCT/BE2004/000171) (mailed Jun. 27, 2005).
Written Opinion of the International Searching Authority (PCT/BE2004/000171) (mailed Jun. 27, 2005).
Astrup, T. et al., “Polysaccharide Sulfuric Acids as Anticoagulants,”Acta Phys. Scand. 8: 215-226, 1944.
McPherson et al., “Articular Cartilage Injury,” Langer, R., Lanza, RP., & Vacanti, J. (Eds.) Principles of Tissue Engineering, Second Edition.Acad. Press697-709, 2000.
Sledge, “Microfracture Techniques in the Treatment of Osteochondral Injuries,”Clin. Sports Med. 20: 1-15, 2001.
Steadman et al., “Microfracture: Surgical Technique and Rehabilitation to Treat Chondral Defects,”Clin Ortho. and Related Research391S: S362-S369, 2001.
The Merck Index: An Encyclopedia of Chemicals, Drugs, and Biologicals, 12th ed. Budavari, S.; O'Neal, M.J.; Smith, A.; Heckelman, P.E.; Kinneary, J.F., Eds.; Merck & Co.: Whitehouse Station, NJ, p. 45, 1996.

Affiliated with

Also associated with

Rating

Use of polysulphated alginate in cellular matrices does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of polysulphated alginate in cellular matrices, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of polysulphated alginate in cellular matrices will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2746562